Neos Therapeutics, Inc. Gains 49.02%

Neos Therapeutics, Inc. (NEOS:NASDAQ) rocketted at $0.86, representing a gain of 49%. On Tue 20 Oct 20, NEOS:NASDAQ touched a New 2-Week High of $0.58. The stock got featured on our News Catalysts scanner on Fri 09 Oct 20 at 03:55 AM in the 'MISCELLANEOUS' category. From Tue 06 Oct 20, the stock recorded 30.00% Up Days and 27.27% Green Days
The share price of the company has been moving sideways in recent weeks.
About Neos Therapeutics, Inc. (NEOS:NASDAQ)
Neos Therapeutics Inc is a pharmaceutical company, engaged in the development, manufacture, and commercialization of products for the treatment of attention deficit hyperactivity disorder using its drug delivery technologies.
Top 10 Gainers:
- Insignia Systems, Inc. (ISIG:NASDAQ), 154.99%
- Marin Software Incorporated (MRIN:NASDAQ), 150.67%
- Astrotech Corporation (ASTC:NASDAQ), 61.45%
- Teligent, Inc. (TLGT:NASDAQ), 49.29%
- Neos Therapeutics, Inc. (NEOS:NASDAQ), 49.02%
- CBX (Listing Market NYSE Networ (CBX:NYSE), 47.54%
- Tengasco, Inc. (TGC:NYSEMKT), 46.32%
- Puhui Wealth Investment Management Co., Ltd. (PHCF:NASDAQ), 41.77%
- China Xiangtai Food Co., Ltd. (PLIN:NASDAQ), 34.88%
- TMBR (TMBR:NYSEMKT), 34.51%